Physician profile
Paula Pons
NPI 1679533483
$177,686.86
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $15K · 2021: $72K · 2022: $44K · 2023: $15K · 2024: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $1,759 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Food and Beverage: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,500.00 |
| Travel and Lodging | $1,758.89 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Food and Beverage | $1,152.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $174,957.81 | 2019-2024 | Puraply Antimicrobial, Affinity, Puraply |
| Kerecis Limited | $1,642.80 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Angiodynamics, INC. | $439.89 | 2019 | |
| Smith+Nephew, INC. | $142.80 | 2019-2023 | Iodosorb Ointment 40g USA, Collagenase Santyl |
| Integra Lifesciences Corporation | $122.89 | 2019-2020 | |
| Abbvie INC. | $89.13 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $55.63 | 2021-2023 | |
| Osiris Therapeutics INC. | $47.88 | 2019 | |
| Intuitive Surgical, INC. | $40.36 | 2022 | |
| Paratek Pharmaceuticals, INC. | $35.48 | 2022-2023 | Nuzyra |
| Allergan, INC. | $27.15 | 2019 | |
| Hydrofera LLC | $26.99 | 2023 | Hydrofera Blue |
| Molnlycke Health Care US, LLC | $22.60 | 2024 | Mepilex Border Flex, Mepitel One, Mepilex |
| Aroa Biosurgery Incorporated | $19.29 | 2019 | |
| Tactile Systems Technology INC | $16.16 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Pons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.